Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $7.05 billion. The enterprise value is $6.96 billion.
Important Dates
The last earnings date was Monday, November 2, 2026, before market open.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 52.60 million shares outstanding. The number of shares has increased by 4.68% in one year.
| Current Share Class | 52.60M |
| Shares Outstanding | 52.60M |
| Shares Change (YoY) | +4.68% |
| Shares Change (QoQ) | +1.25% |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 79.55% |
| Float | 44.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 60.05 |
| PS Ratio | 8.15 |
| Forward PS | 5.43 |
| PB Ratio | 66.82 |
| P/TBV Ratio | 122.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 2.13.
| Current Ratio | 1.42 |
| Quick Ratio | 1.29 |
| Debt / Equity | 2.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.65 |
Financial Efficiency
Return on equity (ROE) is -175.59% and return on invested capital (ROIC) is -32.83%.
| Return on Equity (ROE) | -175.59% |
| Return on Assets (ROA) | -13.65% |
| Return on Invested Capital (ROIC) | -32.83% |
| Return on Capital Employed (ROCE) | -51.53% |
| Weighted Average Cost of Capital (WACC) | 8.71% |
| Revenue Per Employee | $622,495 |
| Profits Per Employee | -$113,160 |
| Employee Count | 1,390 |
| Asset Turnover | 1.16 |
| Inventory Turnover | 1.76 |
Taxes
In the past 12 months, AXSM has paid $646,000 in taxes.
| Income Tax | 646,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.94% in the last 52 weeks. The beta is 0.83, so AXSM's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -7.94% |
| 50-Day Moving Average | 167.08 |
| 200-Day Moving Average | 196.29 |
| Relative Strength Index (RSI) | 35.23 |
| Average Volume (20 Days) | 1,155,933 |
Short Selling Information
The latest short interest is 3.26 million, so 6.20% of the outstanding shares have been sold short.
| Short Interest | 3.26M |
| Short Previous Month | 3.11M |
| Short % of Shares Out | 6.20% |
| Short % of Float | 7.30% |
| Short Ratio (days to cover) | 3.34 |
Income Statement
In the last 12 months, AXSM had revenue of $865.27 million and -$157.29 million in losses. Loss per share was -$3.05.
| Revenue | 865.27M |
| Gross Profit | 806.85M |
| Operating Income | -163.38M |
| Pretax Income | -156.65M |
| Net Income | -157.29M |
| EBITDA | -152.80M |
| EBIT | -163.38M |
| Loss Per Share | -$3.05 |
Full Income Statement Balance Sheet
The company has $313.86 million in cash and $224.23 million in debt, with a net cash position of $89.63 million or $1.70 per share.
| Cash & Cash Equivalents | 313.86M |
| Total Debt | 224.23M |
| Net Cash | 89.63M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 105.43M |
| Book Value Per Share | 2.01 |
| Working Capital | 214.92M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$81.77 million and capital expenditures -$839,000, giving a free cash flow of -$82.61 million.
| Operating Cash Flow | -81.77M |
| Capital Expenditures | -839,000 |
| Depreciation & Amortization | 10.58M |
| Net Borrowing | -3.84M |
| Free Cash Flow | -82.61M |
| FCF Per Share | -$1.57 |
Full Cash Flow Statement Margins
Gross margin is 93.25%, with operating and profit margins of -18.88% and -18.18%.
| Gross Margin | 93.25% |
| Operating Margin | -18.88% |
| Pretax Margin | -18.10% |
| Profit Margin | -18.18% |
| EBITDA Margin | -17.66% |
| EBIT Margin | -18.88% |
| FCF Margin | n/a |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.68% |
| Shareholder Yield | -4.68% |
| Earnings Yield | -2.28% |
| FCF Yield | -1.17% |
Analyst Forecast
The average price target for AXSM is $264.62, which is 97.48% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $264.62 |
| Price Target Difference | 97.48% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 47.67% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 6.22 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.22 |
| Piotroski F-Score | 3 |